Zobrazeno 1 - 10
of 5 063
pro vyhledávání: '"PROTHROMBIN COMPLEX"'
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 3, Pp 603-614 (2024)
Abstract Introduction We previously conducted a prospective, observational post-marketing surveillance study to assess the safety and effectiveness of four-factor prothrombin complex concentrate (4F-PCC) for rapid vitamin K antagonist (VKA) reversal
Externí odkaz:
https://doaj.org/article/1a5d17d319d947f9af25c30b9c8463b4
Publikováno v:
Hematology Reports, Vol 16, Iss 3, Pp 454-464 (2024)
Background: Fresh frozen plasma (FFP) transfusions have been the mainstay of hemostatic intervention for the treatment of bleeding and coagulation abnormalities arising during liver transplantation (LT) for decades. However, numerous clinical studies
Externí odkaz:
https://doaj.org/article/d18a5563acae4574bbaaa136220325a4
Autor:
Elia Morando, Lorenzo Losso, Massimo Carollo, Ilaria Costantini, Matilde Bacchion, Lucia Drezza, Giorgio Ricci
Publikováno v:
Heliyon, Vol 10, Iss 21, Pp e39347- (2024)
This case report examines the combined use of fibrinogen concentrate, four-factor prothrombin complex concentrate (PCC), and idarucizumab, a specific antidote for dabigatran, to reverse the anticoagulant effects of dabigatran and apixaban-induced coa
Externí odkaz:
https://doaj.org/article/4a3440642db144bc91b15d166354da64
Publikováno v:
Акушерство, гинекология и репродукция, Vol 18, Iss 2, Pp 180-187 (2024)
Aim: to develop enzyme-linked immunosorbent tests for assessing the antiphospholipid syndrome (APS) markers and determine prevalence of three antiphospholipid antibody (aPL) types at different COVID-19 stages. Materials and Methods. A comparative lon
Externí odkaz:
https://doaj.org/article/4ca65a1ac3db4db68a890328d01149c0
Autor:
Tatiana M. Reshetnyak, Fariza A. Cheldieva, Svetlana I. Glukhova, Kamila S. Nurbaeva, Nataliya V. Seredavkina, Mariya V. Cherkasova, Alexander M. Lila, Evgeny L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 4 (2024)
Thrombotic antiphospholipid syndrome (APS) is a condition affecting young people in whom a thromboembolic event occurs in the presence of circulating antiphospholipid antibodies (aPL).The aim of this study was the evaluation of the incidence of recur
Externí odkaz:
https://doaj.org/article/1428993700ed44f597b48a871e1f56c7
Autor:
Masahiro Yasaka, Michiyasu Suzuki, Shigeki Kushimoto, Ayako Kiyonaga, Antoinette Mangione, Yuki Niwa, Naoki Terasaka
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 1, Pp 221-232 (2024)
Abstract Introduction Limited data are available regarding the safety and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) in patients experiencing major hemorrhage or requiring expeditious surgical intervention, both globally and w
Externí odkaz:
https://doaj.org/article/d4adaa8ecf32426585e131af40635f43
Autor:
Patricia Viana, Jessica Hoffmann Relvas, Marina Persson, Thamiris Dias Delfino Cabral, Jorge Eduardo Persson, Jessica Sales de Oliveira, Paulo Bonow, Camila Veronica Souza Freire, Sara Amaral
Publikováno v:
Journal of Chest Surgery, Vol 57, Iss 1, Pp 25-35 (2024)
Background: Prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP) are commonly used to manage bleeding in patients during cardiac surgery. However, the relative efficacy and safety of these 2 strategies remain uncertain. Methods: MED
Externí odkaz:
https://doaj.org/article/547e04b0bbed439e97427fda3660a7f4
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 12, Pp 1143-1147 (2023)
Objective To determine the optimal process conditions for efficiently extracting human prothrombin complex concentrates from human plasma. Methods Using human plasma as the materials and the yield of prothrombin complex concentrates as the evaluation
Externí odkaz:
https://doaj.org/article/1e5045dcf1984fc8a89afea4f5f1191c
Autor:
Yong LIU, Yurong YU, Long YANG, Zexiu LI, Yao ZHANG, Jing DENG, Dan LI, Yunhua CHEN, Xuemei ZHAO
Publikováno v:
Zhongguo shuxue zazhi, Vol 36, Iss 9, Pp 818-822 (2023)
Objective To establish an enzyme-linked immunosorbent assay (ELISA) method for the determination of residual human coagulation factor Ⅺ in human prothrombin complex and validate the method. Methods Human factor Ⅺ was reacted with the capture anti
Externí odkaz:
https://doaj.org/article/bd4659b7d49c488ca1f623d7b72b56b8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.